Ticker	Volume	Price	Price Delta
DJIA	15,318.20	+138.38	0.91%
S&P 500	1,651.81	+12.77	0.78%
Nasdaq	3,482.18	+30.05	0.87%

Ticker

Volume

Price

Price Delta

DJIA

15,318.20

+138.38

0.91%

S&P 500

1,651.81

+12.77

0.78%

Nasdaq

3,482.18

+30.05

0.87%

Ticker	Volume	Price	Price Delta
STOXX 50	2,700.93	-1.76	-0.07%
FTSE 100	6,374.21	+43.72	0.69%
DAX	8,229.51	+13.78	0.17%

Ticker

Volume

Price

Price Delta

STOXX 50

2,700.93

-1.76

-0.07%

FTSE 100

6,374.21

+43.72

0.69%

DAX

8,229.51

+13.78

0.17%

Ticker	Volume	Price	Price Delta
Nikkei	13,280.20	+272.96	2.10%
Hang Seng	21,131.50	-94.42	-0.44%
S&P/ASX 200	4,840.80	+26.45	0.55%

Ticker

Volume

Price

Price Delta

Nikkei

13,280.20

+272.96

2.10%

Hang Seng

21,131.50

-94.42

-0.44%

S&P/ASX 200

4,840.80

+26.45

0.55%

Novartis Board Member Sold 1.41 Million Shares, Bilanz Says

By Allison Connolly - 2012-01-12T10:12:01Z

Novartis AG (NOVN) board member Pierre Landolt sold 1.41 million shares in the Basel, Switzerland-based drugmaker, Bilanz reported today, disputing a report that it was the chairman and citing a person familiar with the transaction.

A report in Blick on Dec. 21 said Novartis Chairman Daniel Vasella sold shares worth 73.2 million francs ($77 million).

Eric Althoff, a spokesman for Novartis, didn’t immediately return a call and e-mail today seeking comment.

To contact the reporter on this story: Allison Connolly in Frankfurt at aconnolly4@bloomberg.net.

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net.

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.